Willingness to pay for a cure of low-risk melanoma patients in Germany
Standard
Willingness to pay for a cure of low-risk melanoma patients in Germany. / Augustin, Matthias; Blome, Christine; Forschner, Andrea; Gutzmer, Ralf; Hauschild, Axel; Heinzerling, Lucie; Livingstone, Elisabeth; Loquai, Carmen; Schadendorf, Dirk; Utikal, Jochen; Wagner, Tobias; Wilden, S.; Kähler, Katharina.
In: PLOS ONE, Vol. 13, No. 5, 24.05.2018, p. e0197780.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Willingness to pay for a cure of low-risk melanoma patients in Germany
AU - Augustin, Matthias
AU - Blome, Christine
AU - Forschner, Andrea
AU - Gutzmer, Ralf
AU - Hauschild, Axel
AU - Heinzerling, Lucie
AU - Livingstone, Elisabeth
AU - Loquai, Carmen
AU - Schadendorf, Dirk
AU - Utikal, Jochen
AU - Wagner, Tobias
AU - Wilden, S.
AU - Kähler, Katharina
PY - 2018/5/24
Y1 - 2018/5/24
N2 - Malignant melanoma is potentially life-threatening but in most cases curable if detected early. Willingness to pay (WTP) is a preference-based construct that reflects burden of disease by assessment of the monetary value for a hypothetical cure from disease. Since WTP (directly as total amount of money) has not been assessed so far in patients with low risk melanoma, it was interesting to gain insights in this patient population and then, in a second step, compare it directly with the WTP of their treating dermato-oncologists. WTP was assessed in 125 patients with low-risk melanoma and additionally in 105 treating physicians, asking for the one-time and continuous payments they would be willing to make for a sustainable cure, both as absolute sums and as percentages of monthly income. The median WTP based on one-time payment was (sic)10,000 for patients and (sic)100,000 for physicians; relative numbers were 100% versus 300% of monthly income. For continuous monthly payments, WTP was (sic)500 for patients and (sic)1000 for physicians, relative numbers 25% and 50% of income, respectively. Even after controlling for income differences, there was a significantly higher WTP in physicians for all four questions. Compared to patients with chronic skin diseases such as vitiligo, rosacea, atopic eczema and psoriasis, patients with low-risk melanoma showed a significantly higher WTP. Our data suggest that there is a relevant burden of disease even in patients with low-risk tumors. Higher WTP of physicians underlines the prevalence of differences in disease perception.
AB - Malignant melanoma is potentially life-threatening but in most cases curable if detected early. Willingness to pay (WTP) is a preference-based construct that reflects burden of disease by assessment of the monetary value for a hypothetical cure from disease. Since WTP (directly as total amount of money) has not been assessed so far in patients with low risk melanoma, it was interesting to gain insights in this patient population and then, in a second step, compare it directly with the WTP of their treating dermato-oncologists. WTP was assessed in 125 patients with low-risk melanoma and additionally in 105 treating physicians, asking for the one-time and continuous payments they would be willing to make for a sustainable cure, both as absolute sums and as percentages of monthly income. The median WTP based on one-time payment was (sic)10,000 for patients and (sic)100,000 for physicians; relative numbers were 100% versus 300% of monthly income. For continuous monthly payments, WTP was (sic)500 for patients and (sic)1000 for physicians, relative numbers 25% and 50% of income, respectively. Even after controlling for income differences, there was a significantly higher WTP in physicians for all four questions. Compared to patients with chronic skin diseases such as vitiligo, rosacea, atopic eczema and psoriasis, patients with low-risk melanoma showed a significantly higher WTP. Our data suggest that there is a relevant burden of disease even in patients with low-risk tumors. Higher WTP of physicians underlines the prevalence of differences in disease perception.
KW - Adult
KW - Aged
KW - Cost of Illness
KW - Female
KW - Germany
KW - Humans
KW - Income
KW - Male
KW - Melanoma/economics
KW - Middle Aged
KW - Neoplasm Staging
KW - Odds Ratio
KW - Patient Preference
KW - Physicians/psychology
KW - Skin Neoplasms/economics
KW - Surveys and Questionnaires
U2 - 10.1371/journal.pone.0197780
DO - 10.1371/journal.pone.0197780
M3 - SCORING: Journal article
C2 - 29795621
VL - 13
SP - e0197780
JO - PLOS ONE
JF - PLOS ONE
SN - 1932-6203
IS - 5
ER -